# Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome

> **NCT02271360** · PHASE2,PHASE3 · COMPLETED · sponsor: **Benha University** · enrollment: 200 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Calcium Dobesilate
- **DRUG:** Cabergoline

## Key facts

- **NCT ID:** NCT02271360
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2017-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02271360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02271360, "Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02271360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*